These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 8540313
1. A minute gastric cancer detected by a new screening method using serum pepsinogen I and II. Yahagi N, Miki K, Ichinose M, Kakei N, Matsushima M, Kido M, Shimizu Y, Ishihama S, Tsukada S, Kurokawa K. Adv Exp Med Biol; 1995; 362():145-8. PubMed ID: 8540313 [No Abstract] [Full Text] [Related]
2. Two cases of early colorectal cancer associated with gastric adenoma detected by serum pepsinogen screening method. Shimizu Y, Kakei N, Wada T, Yahagi N, Kido M, Ishihama S, Tsukada S, Matsushima M, Ichinose M, Miki K. Adv Exp Med Biol; 1995; 362():149-54. PubMed ID: 8540314 [No Abstract] [Full Text] [Related]
3. The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography. Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Tanaka S, Kajiyama G, Shigenobu T. Hiroshima J Med Sci; 1997 Jun; 46(2):81-6. PubMed ID: 9232936 [Abstract] [Full Text] [Related]
4. Evaluation of cutoff levels for screening of gastric cancer using serum pepsinogens and distributions of levels of serum pepsinogen I, II and of PG I/PG II ratios in a gastric cancer case-control study. Aoki K, Misumi J, Kimura T, Zhao W, Xie T. J Epidemiol; 1997 Sep; 7(3):143-51. PubMed ID: 9337512 [Abstract] [Full Text] [Related]
6. [Evaluation on a gastric mass survey-comparison with gastric mass screening using photofluorography and that using serum pepsinogen]. Tomooka Y. Nihon Koshu Eisei Zasshi; 1996 Feb; 43(2):118-25. PubMed ID: 8901216 [No Abstract] [Full Text] [Related]
7. Sensitivity and specificity of mass screening for gastric cancer using the measurment of serum pepsinogens. Hattori Y, Tashiro H, Kawamoto T, Kodama Y. Jpn J Cancer Res; 1995 Dec; 86(12):1210-5. PubMed ID: 8636012 [Abstract] [Full Text] [Related]
8. [Mass screening of stomach neoplasms by serum pepsinogen analysis]. Miki K. Nihon Naika Gakkai Zasshi; 1992 May 10; 81(5):654-9. PubMed ID: 1512496 [No Abstract] [Full Text] [Related]
9. [Mass screening of gastric cancer--limits and prospects]. Yamaki G, Higashi K. Gan To Kagaku Ryoho; 2002 Nov 10; 29(11):1883-7. PubMed ID: 12465385 [Abstract] [Full Text] [Related]
10. The association of smoking and drinking habits with serum pepsinogens. Kikuchi S, Inaba Y, Wada O, Miki K, Tenjin H, Kaneko E, Mizukoshi H. Int J Epidemiol; 1995 Apr 10; 24(2):346-53. PubMed ID: 7635595 [Abstract] [Full Text] [Related]
11. Evaluation of pepsinogen A and gastrin-17 as markers of gastric cancer and high-risk pathologic conditions. Hallissey MT, Dunn JA, Fielding JW. Scand J Gastroenterol; 1994 Dec 10; 29(12):1129-34. PubMed ID: 7886402 [Abstract] [Full Text] [Related]
15. Serum pepsinogen as a new marker for gastric carcinoma among young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults. Kikuchi S, Wada O, Miki K, Nakajima T, Nishi T, Kobayashi O, Inaba Y. Cancer; 1994 Jun 01; 73(11):2695-702. PubMed ID: 8194008 [Abstract] [Full Text] [Related]
16. [Pepsinogen]. Miki K. Nihon Rinsho; 1995 May 01; 53(5):1198-202. PubMed ID: 7602778 [Abstract] [Full Text] [Related]